Moinard-Butot, F., Saint-Martin, C., Pflumio, C., Carton, M., Jacot, W., Cottu, P., . . . Petit, T. (2022). Efficacy of trastuzumab emtansine (T-DM1) and lapatinib after dual HER2 inhibition with trastuzumab and pertuzumab in patient with metastatic breast cancer: Retrospective data from a French multicenter real-life cohort. Breast (Edinburgh), 63, 54-60. https://doi.org/10.1016/j.breast.2022.03.004
Chicago-Zitierstil (17. Ausg.)Moinard-Butot, Fabien, et al. "Efficacy of Trastuzumab Emtansine (T-DM1) and Lapatinib After Dual HER2 Inhibition with Trastuzumab and Pertuzumab in Patient with Metastatic Breast Cancer: Retrospective Data from a French Multicenter Real-life Cohort." Breast (Edinburgh) 63 (2022): 54-60. https://doi.org/10.1016/j.breast.2022.03.004.
MLA-Zitierstil (9. Ausg.)Moinard-Butot, Fabien, et al. "Efficacy of Trastuzumab Emtansine (T-DM1) and Lapatinib After Dual HER2 Inhibition with Trastuzumab and Pertuzumab in Patient with Metastatic Breast Cancer: Retrospective Data from a French Multicenter Real-life Cohort." Breast (Edinburgh), vol. 63, 2022, pp. 54-60, https://doi.org/10.1016/j.breast.2022.03.004.